Mr. Marco Prinz serves as the Director of the Institute of Neuropathology at the University Hospital Freiburg, Germany. He graduated as an M.D. from the Medical School Charité of Humboldt University, Berlin. Subsequently, he joined the Molecular Neuroscience Laboratory of H.Kettenmann at the Max Delbrück Center (MDC) for Molecular Medicine in Berlin-Buch and started first work on microglia. After this period he was a postdoctoral fellow at the Institute of Neuropathology led by A.Aguzzi at the University Hospital Zurich, Medical School, Switzerland. Shortly after, he moved to Göttingen, Germany to continue his research on the brains immune system and became a lecturer and consultant in neuropathology. In 2008 he was appointed as Director of the Institute of Neuropathology at the University Hospital Freiburg, Germany.
His current research focuses on the brain-specific immune functions during health and disease (autoimmune and neurodegenerative CNS disorders) and the fate of microglia in the brain. His group investigates the role of type I interferons such as IFN-alpha/beta for autoimmune inflammation (Prinz et al. Immunity 2008; Dann et al. Nat Neurosci 2011). Furthermore, the origin and function if microglia are of special interest for his research team (Goldmann et al. Nat Neurosci, 2013, Kierdorf et al. Nat Neurosci, 2013, Mildner et al. Nat Neurosci 2007, Prinz et al. Nat Neurosci 2011).